At NINGBO INNO PHARMCHEM CO.,LTD., we are committed to advancing the field of pharmaceuticals through the supply of high-quality chemical intermediates. One such critical compound is Methyl 4-(Bromomethyl)-3-Methoxybenzoate, identified by its CAS number 70264-94-7. This article delves into its significance, particularly as a key component in the synthesis of Zafirlukast, a groundbreaking medication for asthma management. We aim to illuminate the properties and applications that make this chemical a cornerstone in modern pharmaceutical production.

Methyl 4-(Bromomethyl)-3-Methoxybenzoate is a white to off-white crystalline powder, a characteristic that speaks to its purity and suitability for sensitive pharmaceutical applications. Its molecular formula, C10H11BrO3, and molecular weight of 259.096 g/mol, are precisely defined, ensuring consistency in chemical reactions. The compound's melting point, typically between 92-94°C, and its high assay of ≥98.0% (often determined by HPLC), underscore its status as a premium pharmaceutical intermediate. These attributes are paramount for manufacturers seeking reliable and effective raw materials for complex synthesis pathways.

The primary and most significant application of Methyl 4-(Bromomethyl)-3-Methoxybenzoate lies in its indispensable role in the Zafirlukast intermediate synthesis. Zafirlukast is a highly selective and long-acting oral leukotriene receptor antagonist, renowned for its efficacy in managing chronic asthma. Leukotrienes are inflammatory mediators that play a pivotal role in the pathogenesis of asthma, contributing to bronchoconstriction and inflammation. By antagonizing these leukotriene receptors, Zafirlukast effectively reduces asthma symptoms and improves lung function. The bromomethyl group within Methyl 4-(Bromomethyl)-3-Methoxybenzoate is instrumental in facilitating the chemical reactions necessary to construct the complex molecular architecture of Zafirlukast, making it a vital building block.

The demand for effective asthma treatments continues to grow globally, and consequently, the demand for reliable asthma medication intermediate supplies like Methyl 4-(Bromomethyl)-3-Methoxybenzoate is also on the rise. Companies that specialize in pharmaceutical intermediate chemical production, such as NINGBO INNO PHARMCHEM CO.,LTD., play a critical role in ensuring the consistent availability of this compound. We understand the importance of quality control and regulatory compliance in the pharmaceutical sector. Our production processes adhere to stringent standards to deliver a product that not only meets but often exceeds the purity requirements for Zafirlukast intermediate synthesis.

Beyond its direct role in Zafirlukast production, Methyl 4-(Bromomethyl)-3-Methoxybenzoate is also valuable within broader organic synthesis and the fine chemical industry. Its unique chemical structure and reactive sites make it a versatile compound for researchers exploring new drug candidates or optimizing existing synthetic routes. The availability of high purity methyl 4-(bromomethyl)-3-methoxybenzoate from reputable suppliers ensures that these research and development efforts can proceed with confidence. As a testament to its importance, this compound is sought after by pharmaceutical manufacturers worldwide who require dependable access to fine chemical CAS 70264-94-7 for their production needs.

At NINGBO INNO PHARMCHEM CO.,LTD., we are proud to contribute to advancements in healthcare by providing essential chemical intermediates. Our expertise in custom synthesis, process development, and large-scale production allows us to meet the diverse needs of the pharmaceutical industry. We continuously strive to enhance our capabilities to support the development of life-saving and life-improving medications. For those seeking reliable suppliers of pharmaceutical intermediate chemical or require specific information on Zafirlukast intermediate synthesis, we encourage you to contact us for tailored solutions and quotations.